Price$96.10-0.32 (-0.33%)
01:30 PM07:45 PM
News · 26 weeks81+200%
2026-01-182026-07-12
Mix4290d
- Insider25(60%)
- SEC Filings5(12%)
- Other6(14%)
- Dividends2(5%)
- Earnings2(5%)
- Analyst2(5%)
Latest news
25 items- INSIDERDirector Smith Maurice S was granted 128 shares, increasing direct ownership by 0.41% to 31,311 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Embler Michael J was granted 72 shares, increasing direct ownership by 0.37% to 19,274 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Nader Marguerite M was granted 72 shares, increasing direct ownership by 0.31% to 23,544 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Roy Sumit was granted 119 shares, increasing direct ownership by 0.48% to 24,872 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Martino Roxanne M was granted 174 shares, increasing direct ownership by 0.26% to 66,846 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Lustig Matthew J was granted 281 shares, increasing direct ownership by 0.29% to 95,735 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Rodriguez Joe Vasquez Jr. was granted 49 shares, increasing direct ownership by 0.49% to 9,943 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Barnes Melody C was granted 72 shares, increasing direct ownership by 0.20% to 35,379 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- ANALYSTBarclays initiated coverage on Ventas with a new price targetBarclays initiated coverage of Ventas with a rating of Equal Weight and set a new price target of $99.00
- INSIDERDirector Smith Maurice S was granted 461 shares, increasing direct ownership by 2% to 31,184 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Roy Sumit was granted 349 shares, increasing direct ownership by 1% to 24,753 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Martino Roxanne M was granted 544 shares, increasing direct ownership by 0.82% to 66,672 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Lustig Matthew J was granted 448 shares, increasing direct ownership by 0.47% to 95,453 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- PRVentas Announces Second Quarter 2026 Earnings Release Date and Conference CallVentas, Inc. (NYSE:VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and w
- PRVentas Names Andrew L. Wattula EVP Outpatient Medical & ResearchVentas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, a wholly-owned property management and leasing subsidiary of Ventas, effective August 2026. He will oversee the Company’s differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersection of medicine, research and universities. He succeeds Peter J. Bulgarelli, who retired from Ventas in May 2026. Wattula brings deep operational, leasing and tenant engagement expertise to Ventas. Working with the Company’s in-
- ANALYSTRaymond James resumed coverage on Ventas with a new price targetRaymond James resumed coverage of Ventas with a rating of Outperform and set a new price target of $94.00
- SECVentas Inc. filed SEC Form 8-K: Leadership Update, Other Events8-K - Ventas, Inc. (0000740260) (Filer)
- INSIDERDirector Embler Michael J bought $197,025 worth of shares (2,500 units at $78.81), increasing direct ownership by 15% to 19,202 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- PRVentas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate AchievementVentas, Inc. (NYSE:VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum's 32nd Annual Making History Awards this evening. The Cyrus McCormick Making History Award for Historic Corporate Achievement recognizes business leaders and organizations whose work has made enduring contributions to Chicago's economic and civic life. Under Cafaro's leadership, Ventas has grown into one of the world's leading enterprises at the center of the longevity economy, with ownership of over 1,400 properties and a mission focused on serving a large and growing aging
- PRVentas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor ConferenceVentas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today announced that it has issued an investor presentation, which is available on the Company's website at ir.ventasreit.com/events-and-presentations. Company management will participate in investor meetings at Nareit's REITweek 2026 Investor Conference. About Ventas Ventas, Inc. (NYSE:VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 900 senior housing communities, which provide valuable ser
- SECVentas Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events8-K - Ventas, Inc. (0000740260) (Filer)
- INSIDERDirector Roy Sumit was granted 2,047 shares, increasing direct ownership by 9% to 24,404 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Smith Maurice S was granted 2,047 shares, increasing direct ownership by 7% to 30,723 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Rakowich Walter C was granted 2,047 shares and sold $103,915 worth of shares (1,152 units at $90.20) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 28,349 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
- INSIDERDirector Rodriguez Joe Vasquez Jr. was granted 2,047 shares, increasing direct ownership by 26% to 9,895 units (SEC Form 4)4 - Ventas, Inc. (0000740260) (Issuer)
VTR FAQ
7 questionsWhat does Ventas Inc. do?
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of...Where does VTR stock trade?
Ventas Inc. (VTR) is listed on NYSE.What sector and industry is VTR in?
Ventas Inc. operates in the Real Estate sector, Real Estate Investment Trusts industry.Does VTR pay a dividend?
VTR's most recent ex-dividend date was 2026-06-30 with a cash dividend of $0.52 per share. No future ex-date is on file yet.What are analysts saying about VTR?
Ventas Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight on 2026-07-07.What companies are similar to VTR?
Notable peers in the same industry include WELL (Welltower Inc.), OHI (Omega Healthcare Investors Inc.), SBRA (Sabra Health Care REIT Inc.), CTRE (CareTrust REIT Inc.). Compare VTR side-by-side with any of them on Quantisnow.How can I track VTR on Quantisnow?
Quantisnow aggregates Ventas Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VTR to receive live email and push alerts on every new disclosure.